Dynamics in Post-pandemic Global Non-Invasive Prenatal Testing Industry: Supply and Demand, Markets and Prices 2021-2027
Report Code: KNJ662236 No. of Pages: 119 Category: Pharmaceuticals and Healthcare
Publisher: Date of Publish:
Publisher: Date of Publish:
Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Non-Invasive Prenatal Testing market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Non-Invasive Prenatal Testing market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027. Segmented by Category High & Average Risk Low Risk Segmented by End User/Segment 0-12 Weeks 13-24 Weeks 25-36 Weeks Segmented by Country North America United States Canada Mexico Europe Germany France UK Italy Russia Spain Asia Pacific China Japan Korea Southeast Asia India Australasia Central & South America Brazil Argentina Colombia Middle East & Africa Iran Israel Turkey South Africa Saudi Arabia Key manufacturers included in this survey Sequenom Roche Quest Diagnostics Natera LabCorp Illumina BGI Genomics Berry Genomics
Table of Contents
1 Product Introduction and Overview
1.1 Product Definition
1.2 Product Specification
1.3 Global Market Overview
1.3.1 Global Non-Invasive Prenatal Testing Market Status and Forecast (2016-2027)
1.3.2 Global Non-Invasive Prenatal Testing Sales Value CAGR by Region
1.4 Market Drivers, Inhibitors
1.4.1 Market Drivers
1.4.2 Market Inhibitors
1.4.3 COVID-19 Impact Analysis
2 Global Non-Invasive Prenatal Testing Supply by Company
2.1 Global Non-Invasive Prenatal Testing Sales Value by Company
2.2 Non-Invasive Prenatal Testing Sales Area of Main Manufacturers
2.3 Trend of Concentration Rate
3 Global and Regional Non-Invasive Prenatal Testing Market Status by Category
3.1 Non-Invasive Prenatal Testing Category Introduction
3.1.1 High & Average Risk
3.1.2 Low Risk
3.2 Global Non-Invasive Prenatal Testing Market by Category
3.3 North America: by Category
3.4 Europe: by Category
3.5 Asia Pacific: by Category
3.6 Central & South America: by Category
3.7 Middle East & Africa: by Category
4 Global and Regional Non-Invasive Prenatal Testing Market Status by End User/Segment
4.1 Non-Invasive Prenatal Testing Segment by End User/Segment
4.1.1 0-12 Weeks
4.1.2 13-24 Weeks
4.1.3 25-36 Weeks
4.2 Global Non-Invasive Prenatal Testing Market by End User/Segment
4.3 North America: by End User/Segment
4.4 Europe: by End User/Segment
4.5 Asia Pacific: by End User/Segment
4.6 Central & South America: by End User/Segment
4.7 Middle East & Africa: by End User/Segment
5 Global Non-Invasive Prenatal Testing Market Status by Region
5.1 Global Non-Invasive Prenatal Testing Market by Region
5.2 North America Non-Invasive Prenatal Testing Market Status
5.3 Europe Non-Invasive Prenatal Testing Market Status
5.4 Asia Pacific Non-Invasive Prenatal Testing Market Status
5.5 Central & South America Non-Invasive Prenatal Testing Market Status
5.6 Middle East & Africa Non-Invasive Prenatal Testing Market Status
6 North America Non-Invasive Prenatal Testing Market Status
6.1 North America Non-Invasive Prenatal Testing Market by Country
6.2 United States
6.3 Canada
6.4 Mexico
7 Europe Non-Invasive Prenatal Testing Market Status
7.1 Europe Non-Invasive Prenatal Testing Market by Country
7.2 Germany
7.3 France
7.4 UK
7.5 Italy
7.6 Russia
7.7 Spain
8 Asia Pacific Non-Invasive Prenatal Testing Market Status
8.1 Asia Pacific Non-Invasive Prenatal Testing Market by Country
8.2 China
8.3 Japan
8.4 Korea
8.5 Southeast Asia
8.6 India
8.7 Australasia
9 Central & South America Non-Invasive Prenatal Testing Market Status
9.1 Central & South America Non-Invasive Prenatal Testing Market by Country
9.2 Brazil
9.3 Argentina
9.4 Colombia
10 Middle East & Africa Non-Invasive Prenatal Testing Market Status
10.1 Middle East & Africa Non-Invasive Prenatal Testing Market by Country
10.2 Iran
10.3 Israel
10.4 Turkey
10.5 South Africa
10.8 Saudi Arabia
11 Major Downstream Customers Analysis
11.1 Customer One Analysis
11.2 Customer Two Analysis
11.3 Customer Three Analysis
11.4 Customer Four Analysis
12 Global Non-Invasive Prenatal Testing Market Forecast by Category and by End User/Segment
12.1 Global Non-Invasive Prenatal Testing Sales Value Forecast (2022-2027)
12.2 Global Non-Invasive Prenatal Testing Forecast by Category
12.3 Global Non-Invasive Prenatal Testing Forecast by End User/Segment
13 Global Non-Invasive Prenatal Testing Market Forecast by Region/Country
13.1 Global Non-Invasive Prenatal Testing Market Forecast by Region (2022-2027)
13.2 North America Market Forecast
13.3 Europe Market Forecast
13.4 Asia Pacific Market Forecast
13.5 Central & South America Market Forecast
13.6 Middle East & Africa Market Forecast
14 Key Participants Company Information
14.1 Sequenom
14.1.1 Company Information
14.1.2 Non-Invasive Prenatal Testing Product Introduction
14.1.3 Sequenom
Non-Invasive Prenatal Testing Sales Value, Gross Margin and Global Share (2019-2021)
14.1.4 SWOT Analysis
14.2 Roche
14.2.1 Company Information
14.2.2 Non-Invasive Prenatal Testing Product Introduction
14.2.3 Roche
Non-Invasive Prenatal Testing Sales Value, Gross Margin and Global Share (2019-2021)
14.2.4 SWOT Analysis
14.3 Quest Diagnostics
14.3.1 Company Information
14.3.2 Non-Invasive Prenatal Testing Product Introduction
14.3.3 Quest Diagnostics
Non-Invasive Prenatal Testing Sales Value, Gross Margin and Global Share (2019-2021)
14.3.4 SWOT Analysis
14.4 Natera
14.4.1 Company Information
14.4.2 Non-Invasive Prenatal Testing Product Introduction
14.4.3 Natera
Non-Invasive Prenatal Testing Sales Value, Gross Margin and Global Share (2019-2021)
14.4.4 SWOT Analysis
14.5 LabCorp
14.5.1 Company Information
14.5.2 Non-Invasive Prenatal Testing Product Introduction
14.5.3 LabCorp
Non-Invasive Prenatal Testing Sales Value, Gross Margin and Global Share (2019-2021)
14.5.4 SWOT Analysis
14.6 Illumina
14.6.1 Company Information
14.6.2 Non-Invasive Prenatal Testing Product Introduction
14.6.3 Illumina
Non-Invasive Prenatal Testing Sales Value, Gross Margin and Global Share (2019-2021)
14.6.4 SWOT Analysis
14.7 BGI Genomics
14.7.1 Company Information
14.7.2 Non-Invasive Prenatal Testing Product Introduction
14.7.3 BGI Genomics
Non-Invasive Prenatal Testing Sales Value, Gross Margin and Global Share (2019-2021)
14.7.4 SWOT Analysis
14.8 Berry Genomics
14.8.1 Company Information
14.8.2 Non-Invasive Prenatal Testing Product Introduction
14.8.3 Berry Genomics
Non-Invasive Prenatal Testing Sales Value, Gross Margin and Global Share (2019-2021)
14.8.4 SWOT Analysis
15 Conclusion
16 Methodology
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com